2025
SJR Q2
JCR Q3 · 2,3
OA
7 matched articles
ESCI
Journal detail
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
24055794
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,832
- Quartile Q2
- H-Index 31
- Cites/doc 2,32
- Docs (3y) 201
- Cites (3y) 525
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,3
- 5Y JIF 2,5
- JCI 0,54
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Infectious Diseases Q2
- Microbiology (medical) Q2
- Pulmonary and Respiratory Medicine Q2
Areas
- Medicine
WoS categories
- Infectious Diseases | Microbiology | Respiratory System
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,832 | 2,3 | 2,5 | 0,54 | Q3 | 31 |
| 2024 | Q2 | Q3 | 0,721 | 2 | 2,3 | 0,51 | Q3 | 25 |
| 2023 | Q2 | Q3 | 0,653 | 1,9 | — | 0,41 | Q3 | 25 |
| 2022 | Q2 | — | 0,602 | 2 | — | 0,4 | Q3 | 25 |
| 2021 | Q2 | — | 0,608 | — | — | 0,39 | Q3 | 25 |
| 2020 | Q3 | — | 0,585 | — | — | — | — | 25 |
| 2019 | Q2 | — | 0,772 | — | — | — | — | 25 |
| 2017 | Q3 | — | 0,467 | — | — | — | — | 25 |
| 2016 | Q3 | — | 0,166 | — | — | — | — | 25 |
| 2015 | — | — | — | — | — | — | — | 25 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | INFECTIOUS DISEASES | ESCI | Q3 | Q3 | 87/141 |
| 2025 | MICROBIOLOGY | ESCI | Q3 | Q3 | 124/167 |
| 2025 | RESPIRATORY SYSTEM | ESCI | Q3 | Q3 | 60/107 |
| 2024 | INFECTIOUS DISEASES | ESCI | Q3 | Q3 | 91/137 |
| 2024 | MICROBIOLOGY | ESCI | Q3 | Q3 | 122/163 |
| 2024 | RESPIRATORY SYSTEM | ESCI | Q3 | Q3 | 63/108 |
| 2023 | INFECTIOUS DISEASES | ESCI | Q3 | Q3 | 90/132 |
| 2023 | MICROBIOLOGY | ESCI | Q4 | Q4 | 130/161 |
| 2023 | RESPIRATORY SYSTEM | ESCI | Q3 | Q3 | 66/101 |
| 2022 | INFECTIOUS DISEASES | ESCI | — | Q3 | — |
| 2022 | MICROBIOLOGY | ESCI | — | Q4 | — |
| 2022 | RESPIRATORY SYSTEM | ESCI | — | Q3 | — |
| 2021 | INFECTIOUS DISEASES | ESCI | — | Q3 | — |
| 2021 | MICROBIOLOGY | ESCI | — | Q4 | — |
| 2021 | RESPIRATORY SYSTEM | ESCI | — | Q3 | — |